Robert Martinez-Jr. serves as the Region Business Director at Intercept Pharmaceuticals, where he is at the forefront of driving sales and education initiatives for rare diseases, particularly Primary Biliary Cholangitis (PBC) and Non-Alcoholic Steatohepatitis (NASH). With a robust background in the pharmaceutical and biologic sectors,...
Robert Martinez-Jr. serves as the Region Business Director at Intercept Pharmaceuticals, where he is at the forefront of driving sales and education initiatives for rare diseases, particularly Primary Biliary Cholangitis (PBC) and Non-Alcoholic Steatohepatitis (NASH). With a robust background in the pharmaceutical and biologic sectors, Robert has honed his expertise in leading high-performing sales teams that not only meet but exceed ambitious sales goals. His strategic approach combines innovative sales techniques with a deep understanding of the complexities surrounding rare diseases, enabling him to effectively communicate the importance of disease education to healthcare professionals in gastroenterology and hepatology.
In his current role, Robert has successfully recruited and developed a high-caliber sales team, fostering a culture of excellence and accountability. His leadership style emphasizes collaboration and empowerment, ensuring that each team member is equipped with the necessary tools and knowledge to thrive in a competitive market. Under his guidance, the team has achieved significant milestones in market penetration and brand awareness, contributing to Intercept's mission of transforming the treatment landscape for patients with rare liver diseases.
Robert's extensive experience spans various therapeutic areas, including cardiology, diabetes, and neuroscience, allowing him to leverage cross-functional insights to enhance sales strategies. His proficiency in presentations and hospital sales further strengthens his ability to engage with key stakeholders, driving impactful conversations that lead to improved patient outcomes. As a results-driven leader, Robert remains committed to advancing the understanding and treatment of rare diseases, making a meaningful difference in the lives of patients and their families.
